Ming-Tsan Lin Selected Research

Ming-Tsan Lin Research Topics

Disease

36	Neoplasms (Cancer) 01/2021 - 03/2002
25	Stomach Neoplasms (Stomach Cancer) 01/2019 - 04/2002
20	Sepsis (Septicemia) 01/2022 - 07/2002
10	Inflammation (Inflammations) 01/2022 - 09/2002
9	Neoplasm Metastasis (Metastasis) 01/2018 - 02/2003
7	Obesity 02/2022 - 11/2014
7	Wounds and Injuries (Trauma) 01/2022 - 10/2010
6	Body Weight (Weight, Body) 03/2017 - 07/2002
6	Carcinoma (Carcinomatosis) 01/2008 - 01/2002
5	Weight Loss (Weight Reduction) 08/2021 - 11/2014
5	Infections 01/2017 - 04/2002
5	Carcinogenesis 01/2015 - 07/2004
4	Pain (Aches) 01/2022 - 04/2008
4	Hypoxia (Hypoxemia) 11/2021 - 06/2008
4	Insulin Resistance 01/2020 - 05/2015
4	Breast Neoplasms (Breast Cancer) 07/2019 - 02/2003
3	Colorectal Neoplasms (Colorectal Cancer) 09/2016 - 06/2013
3	Lymphatic Metastasis 07/2015 - 03/2002
3	Flatulence 05/2013 - 09/2008
2	Critical Illness (Critically Ill) 01/2021 - 09/2012
2	Fistula 10/2020 - 06/2008
2	Lung Injury 01/2020 - 01/2019
2	Adenocarcinoma 04/2019 - 06/2007
2	Malnutrition (Nutritional Deficiencies) 04/2019 - 03/2008
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 04/2016
2	Colonic Neoplasms (Colon Cancer) 12/2016 - 09/2016
2	Appendicitis 05/2013 - 11/2006
2	Cholecystitis 01/2012 - 01/2009
2	Acute Cholecystitis 01/2012 - 01/2009
2	Neuroblastoma 02/2006 - 03/2005
1	Pneumoperitoneum 01/2022
1	Gallbladder Diseases (Gall Bladder Disease) 01/2022
1	Acute Lung Injury 09/2021
1	Morbid Obesity 08/2021

Drug/Important Bio-Agent (IBA)

14	Glutamine (L-Glutamine)FDA Link 11/2021 - 03/2004
12	CytokinesIBA 11/2021 - 01/2002
9	Proteins (Proteins, Gene)FDA Link 04/2020 - 02/2003
8	salicylhydroxamic acid (SHAM)IBA 04/2020 - 03/2004
7	Messenger RNA (mRNA)IBA 11/2021 - 02/2003
6	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 03/2005
5	IntegrinsIBA 12/2012 - 06/2004
4	Interleukin-6 (Interleukin 6)IBA 04/2019 - 07/2004
4	Indicators and Reagents (Reagents)IBA 04/2011 - 04/2002
3	InterleukinsIBA 04/2020 - 01/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2019 - 01/2002
3	CateninsIBA 12/2016 - 01/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016 - 07/2004
3	RNA (Ribonucleic Acid)IBA 11/2012 - 02/2003
3	Cysteine (L-Cysteine)FDA Link 06/2008 - 11/2007
2	Calcitriol (Calcijex)FDA LinkGeneric 01/2022 - 09/2021
2	Serum AlbuminIBA 01/2021 - 03/2008
2	Lipid PeroxidesIBA 01/2021 - 10/2003
2	Caseins (Casein)FDA Link 04/2020 - 01/2019
2	Arginine (L-Arginine)FDA Link 04/2020 - 01/2020
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2020 - 01/2020
2	Nitric Oxide Synthase (NO Synthase)IBA 04/2020 - 01/2020
2	Insulin (Novolin)FDA Link 01/2020 - 01/2019
2	Connective Tissue Growth FactorIBA 07/2019 - 04/2009
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2019 - 05/2015
2	Therapeutic UsesIBA 01/2018 - 10/2011
2	MicroRNAs (MicroRNA)IBA 01/2017 - 09/2011
2	Plasminogen Activators (Plasminogen Activator)IBA 12/2016 - 06/2008
2	Biomarkers (Surrogate Marker)IBA 07/2015 - 04/2005
2	Vascular Endothelial Growth Factor DIBA 07/2015 - 04/2011
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2015 - 02/2007
2	LigandsIBA 05/2014 - 01/2014
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 05/2014 - 12/2012
2	Chemokine ReceptorsIBA 01/2014 - 11/2007
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2012 - 11/2012
2	Biological ProductsIBA 09/2009 - 02/2006
2	Interleukin-1beta (Interleukin 1 beta)IBA 05/2006 - 09/2002
2	NF-kappa B (NF-kB)IBA 06/2004 - 02/2003
2	EnzymesIBA 10/2003 - 09/2002
2	Interleukin-10 (Interleukin 10)IBA 05/2003 - 01/2002
1	LeptinIBA 02/2022
1	Carbon DioxideIBA 01/2022
1	Volatile Organic CompoundsIBA 01/2022
1	SmokeIBA 01/2022
1	CalpainIBA 11/2021
1	Leucine (L-Leucine)FDA Link 11/2021
1	Vitamin D FDA LinkGeneric 09/2021

Therapy/Procedure

17	Gastrectomy 02/2022 - 11/2006
17	Ligation 01/2022 - 07/2002
17	Punctures 01/2022 - 07/2002
8	Length of Stay 09/2017 - 09/2008
7	Total Parenteral Nutrition 01/2015 - 11/2003
5	Bariatric Surgery 02/2022 - 06/2013
5	Drug Therapy (Chemotherapy) 01/2021 - 06/2003
4	Laparoscopic Cholecystectomy 01/2022 - 01/2009
4	Minimally Invasive Surgical Procedures 01/2022 - 04/2008
4	Therapeutics 01/2020 - 04/2002
3	Gastric Bypass (Roux-en-Y Gastric Bypass) 11/2014 - 06/2008
3	Operative Time 04/2011 - 04/2008
2	Cholecystectomy 01/2022 - 01/2013
2	Intraperitoneal Injections 11/2021 - 01/2015
2	Laparotomy 01/2020 - 10/2011
2	Lymph Node Excision (Lymph Node Dissection) 01/2017 - 04/2011
2	Neoadjuvant Therapy 04/2009 - 04/2002
2	Catheters 07/2007 - 11/2003
1	Injections 11/2021